These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9832055)

  • 21. Study of the diagnostic difference between the clinical diagnostic criteria and results of immunohistochemical staining of multiple primary lung cancers.
    Nonami Y; Ohtuki Y; Sasaguri S
    J Cardiovasc Surg (Torino); 2003 Oct; 44(5):661-5. PubMed ID: 14735056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and alteration of ras and p53 proteins in patients with lung carcinoma accompanied by idiopathic pulmonary fibrosis.
    Takahashi T; Munakata M; Ohtsuka Y; Nisihara H; Nasuhara Y; Kamachi-Satoh A; Dosaka-Akita H; Homma Y; Kawakami Y
    Cancer; 2002 Aug; 95(3):624-33. PubMed ID: 12209756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of chromosome 9 alterations and p53 accumulation in isolated carcinoma in situ of the urinary bladder versus carcinoma in situ associated with carcinoma.
    Hopman AH; Kamps MA; Speel EJ; Schapers RF; Sauter G; Ramaekers FC
    Am J Pathol; 2002 Oct; 161(4):1119-25. PubMed ID: 12368185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis.
    Irving JA; Catasús L; Gallardo A; Bussaglia E; Romero M; Matias-Guiu X; Prat J
    Hum Pathol; 2005 Jun; 36(6):605-19. PubMed ID: 16021566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of double primary adenocarcinoma of the lung with multiple atypical adenomatous hyperplasia.
    Anami Y; Matsuno Y; Yamada T; Takeuchi T; Nakayama H; Hirohashi S; Noguchi M
    Pathol Int; 1998 Aug; 48(8):634-40. PubMed ID: 9736412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discordance of p53 mutations of synchronous colorectal carcinomas.
    Eguchi K; Yao T; Konomoto T; Hayashi K; Fujishima M; Tsuneyoshi M
    Mod Pathol; 2000 Feb; 13(2):131-9. PubMed ID: 10697269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma.
    Wang X; Christiani DC; Mark EJ; Nelson H; Wiencke JK; Gunn L; Wain JC; Kelsey KT
    Cancer; 1999 Apr; 85(8):1734-9. PubMed ID: 10223567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TP53 mutations in synchronous and metachronous bilateral breast carcinomas.
    Suspitsin EN; Due EU; Vu P; Hirvonen A; Børresen-Dale AL; Imyanitov EN
    Cancer Genet Cytogenet; 2008 Jul; 184(2):119-21. PubMed ID: 18617062
    [No Abstract]   [Full Text] [Related]  

  • 29. Involvement of Kruppel-like factor 6 (KLF6) mutation in the development of nonpolypoid colorectal carcinoma.
    Mukai S; Hiyama T; Tanaka S; Yoshihara M; Arihiro K; Chayama K
    World J Gastroenterol; 2007 Aug; 13(29):3932-8. PubMed ID: 17663506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
    Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
    Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients.
    Nishisaka T; Takeshima Y; Inai K
    Hiroshima J Med Sci; 2000 Jun; 49(2):109-16. PubMed ID: 10920577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis.
    Huang J; Behrens C; Wistuba I; Gazdar AF; Jagirdar J
    Ann Diagn Pathol; 2001 Dec; 5(6):321-9. PubMed ID: 11745069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.
    Luo ZG; Tang H; Li B; Zhu Z; Ni CR; Zhu MH
    Oncol Rep; 2011 Apr; 25(4):1073-81. PubMed ID: 21286670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclooxygenase 2 expression and molecular alterations in Peutz-Jeghers hamartomas and carcinomas.
    De Leng WW; Westerman AM; Weterman MA; De Rooij FW; Dekken Hv Hv; De Goeij AF; Gruber SB; Wilson JH; Offerhaus GJ; Giardiello FM; Keller JJ
    Clin Cancer Res; 2003 Aug; 9(8):3065-72. PubMed ID: 12912958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular profiling of synchronous and metachronous cancers of the pancreas reveal molecular mimicry between samples from the same patient.
    Talbott VA; Yeo CJ; Brody JR; Witkiewicz AK
    J Surg Res; 2012 Jul; 176(1):154-8. PubMed ID: 22118834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
    Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
    Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alteration of the p53 gene of lung carcinomas with sarcomatous transformation (spindle cell carcinoma): analysis of four cases.
    Kawano R; Takeshima Y; Inai K
    Pathol Int; 1996 Jan; 46(1):38-45. PubMed ID: 10846548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of heterozygosity is related to p53 mutations and smoking in lung cancer.
    Zienolddiny S; Ryberg D; Arab MO; Skaug V; Haugen A
    Br J Cancer; 2001 Jan; 84(2):226-31. PubMed ID: 11161381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple primary tumors of the upper aerodigestive tract: is there a role for constitutional mutations in the p53 gene?
    Gallo O; Sardi I; Pepe G; Franchi A; Attanasio M; Giusti B; Bocciolini C; Abbate R
    Int J Cancer; 1999 Jul; 82(2):180-6. PubMed ID: 10389749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
    Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.